Paratek Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Paratek Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Paratek Pharmaceuticals Inc
Access all reports
Paratek Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for infectious diseases. The company specializes in antibiotics that address serious bacterial infections, including drug-resistant strains. Paratek's products are designed to provide effective treatment options for conditions such as skin infections and community-acquired bacterial pneumonia. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
PRTK
Country
🇺🇸 United States